CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The NANO-ADJUVANT project aims to develop innovative cancer vaccines for neuroblastoma using novel nanomaterial-based adjuvants. These adjuvants will enhance immune responses by improving antigen presentation and stimulating both antibody and cell-mediated responses.
Neuroblastoma (NB) is a rare, aggressive malignancy primarily affecting children under the age of 5.
Despite significant advancements in treating NB, the disease remains a formidable challenge. A promising approach for NB treatment is the development of therapeutic cancer vaccines with innovative nanomaterial-based adjuvants.
When used as adjuvants, nanomaterials offer several advantages, including efficient migration to lymph nodes, improved antigen presentation by dendritic cells, and cross-pr…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
